OTCMKTS:MRNA - Marina Biotech Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.6713 -0.02 (-2.89 %)
(As of 08/20/2018 04:54 AM ET)
Previous Close$0.6713
Today's Range$0.64 - $0.6713
52-Week Range$0.51 - $3.44
Volume814 shs
Average Volume4,385 shs
Market Capitalization$6.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63
Marina Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of proprietary drug therapeutics primarily for hypertension, arthritis, pain, and oncology in the United States, Europe, and internationally. The company offers Prestalia, a single-pill fixed dose combination (FDC) of perindopril argenine, an angiotensin-converting-enzyme inhibitor; and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug candidates for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to suppress polyps in the precancerous syndrome and orphan indication familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is headquartered in City of Industry, California.

Receive MRNA News and Ratings via Email

Sign-up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:MRNA
CUSIPN/A
Phone626-964-5788

Debt

Debt-to-Equity RatioN/A
Current Ratio0.02
Quick Ratio0.02

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$680,000.00
Price / Sales11.10
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book16.78

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-6,210,000.00
Net MarginsN/A
Return on Equity-692.69%
Return on Assets-103.37%

Miscellaneous

Employees7
Outstanding Shares11,240,000
Market Cap$6.86 million

Marina Biotech (OTCMKTS:MRNA) Frequently Asked Questions

What is Marina Biotech's stock symbol?

Marina Biotech trades on the OTCMKTS under the ticker symbol "MRNA."

How were Marina Biotech's earnings last quarter?

Marina Biotech, Inc. (OTCMKTS:MRNA) released its quarterly earnings results on Friday, May, 18th. The biotechnology company reported ($0.13) earnings per share for the quarter. View Marina Biotech's Earnings History.

When is Marina Biotech's next earnings date?

Marina Biotech is scheduled to release their next quarterly earnings announcement on Monday, August, 20th 2018. View Earnings Estimates for Marina Biotech.

Who are some of Marina Biotech's key competitors?

Who are Marina Biotech's key executives?

Marina Biotech's management team includes the folowing people:
  • Mr. Erik Emerson, Chief Commercial Officer & Director (Age 47)
  • Mr. Robert C. Moscato Jr., CEO & Director (Age 42)
  • Mr. Amit Shah, Chief Financial Officer (Age 52)
  • Mr. Mihir Munsif, Chief Operating Officer (Age 55)
  • Dr. Larn Hwang, Chief Scientific Officer (Age 55)

Has Marina Biotech been receiving favorable news coverage?

Media stories about MRNA stock have trended somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Marina Biotech earned a news and rumor sentiment score of 0.20 on Accern's scale. They also gave press coverage about the biotechnology company an impact score of 46.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Marina Biotech.

How do I buy shares of Marina Biotech?

Shares of MRNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Marina Biotech's stock price today?

One share of MRNA stock can currently be purchased for approximately $0.6713.

How big of a company is Marina Biotech?

Marina Biotech has a market capitalization of $6.86 million and generates $680,000.00 in revenue each year. Marina Biotech employs 7 workers across the globe.

How can I contact Marina Biotech?

Marina Biotech's mailing address is 17870 CASTLETON STREET SUITE 250, CITY OF INDUSTRY CA, 91748. The biotechnology company can be reached via phone at 626-964-5788 or via email at [email protected]


MarketBeat Community Rating for Marina Biotech (OTCMKTS MRNA)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Marina Biotech and other stocks. Vote "Outperform" if you believe MRNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel